TY - JOUR
T1 - Clinical practice guidelines for managing nonvariceal upper gastrointestinal bleeding
AU - Gallach, Marta
AU - Calvet, Xavier
AU - Lanas, Ángel
AU - Feu, Faust
AU - Ponce, Julio
AU - Gisbert, Javier P.
AU - Brullet, Enric
AU - Piñera, Pascual
AU - Castro, Manuel
AU - Martín De Argila, Carlos
AU - Domínguez Muñoz, Enrique
AU - Almela, Pedro
AU - Villanueva, Cándido
AU - González Galilea, Ángel
AU - Pérez Aisa, Ángel
AU - García-Iglesias, Pilar
AU - Gené, Emili
AU - Villoria, Albert
AU - Barkun, Alan
PY - 2013/1/1
Y1 - 2013/1/1
N2 - Nonvariceal upper gastrointestinal (GI) bleeding is a common medical emergency associated with appreciable morbidity and mortality. The significant advances made in managing this condition in recent years have reduced the rates of rebleeding and mortality. These clinical guidelines for managing this emergency are intended to be highly practical, evidence-based, and take recent consensus statements into account. The 3 keys to managing nonvariceal upper GI bleeding are a) early restoration of fluids and blood pressure and the prevention of underlying cardiovascular disease, which is common in these patients; b) endoscopy to treat lesions at high risk of rebleeding; and c) medical therapy with high doses of proton pump inhibitors before and after endoscopy. These 3 measures, used in combination, reduce upper GI rebleeding and mortality rates.
AB - Nonvariceal upper gastrointestinal (GI) bleeding is a common medical emergency associated with appreciable morbidity and mortality. The significant advances made in managing this condition in recent years have reduced the rates of rebleeding and mortality. These clinical guidelines for managing this emergency are intended to be highly practical, evidence-based, and take recent consensus statements into account. The 3 keys to managing nonvariceal upper GI bleeding are a) early restoration of fluids and blood pressure and the prevention of underlying cardiovascular disease, which is common in these patients; b) endoscopy to treat lesions at high risk of rebleeding; and c) medical therapy with high doses of proton pump inhibitors before and after endoscopy. These 3 measures, used in combination, reduce upper GI rebleeding and mortality rates.
KW - Acetylsalicylic acid (ASA)
KW - Clopidogrel
KW - Coagulation
KW - Endoscopy
KW - Gastric ulcer
KW - Gastroscopy
KW - Helicobacter pylori
KW - Nonsteroidal antiinflammatory drugs (NSAIDs)
KW - Nonvariceal upper gastrointestinal bleeding
KW - Proton pump inhibitors
KW - Recurrence
UR - https://www.scopus.com/pages/publications/84900345434
M3 - Article
SN - 1137-6821
VL - 25
SP - 472
EP - 481
JO - Emergencias
JF - Emergencias
IS - 6
ER -